Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1

(2012) Zhu-mei Shi et al.   PLoS One

miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer

(2011) T. Tsuruta et al.   CANCER RESEARCH

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

(2011) Y. Zhu et al.   CLINICAL CANCER RESEARCH

Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations

(2011) Shuling Wang et al.   HISTOPATHOLOGY

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases

(2011) T Papagiannakopoulos et al.   ONCOGENE

Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin

(2010) Kazushi Suzuki et al.   CANCER SCIENCE

Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction

(2010) Balca R. Mardin et al.   NATURE CELL BIOLOGY

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness

(2009) Cristina Evangelisti et al.   FASEB JOURNAL

Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal

(2008) G. Wu et al.   CANCER RESEARCH

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal

(2008) J. Godlewski et al.   CANCER RESEARCH

Nek2 as a novel molecular target for the treatment of breast carcinoma

(2008) Nobuyuki Tsunoda et al.   CANCER SCIENCE

QUMA: quantification tool for methylation analysis

(2008) Y. Kumaki et al.   NUCLEIC ACIDS RESEARCH